1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Bone Marrow 1.2.3 Epidermis 1.3 Market by Application 1.3.1 Global Autologous Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Neurology 1.3.3 Orthopedics 1.3.4 Cancer 1.3.5 Wound Healing 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Autologous Cell Therapy Market Perspective (2016-2027) 2.2 Autologous Cell Therapy Growth Trends by Regions 2.2.1 Autologous Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Autologous Cell Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Autologous Cell Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Autologous Cell Therapy Industry Dynamic 2.3.1 Autologous Cell Therapy Market Trends 2.3.2 Autologous Cell Therapy Market Drivers 2.3.3 Autologous Cell Therapy Market Challenges 2.3.4 Autologous Cell Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Autologous Cell Therapy Players by Revenue 3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2016-2021) 3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Autologous Cell Therapy Revenue 3.4 Global Autologous Cell Therapy Market Concentration Ratio 3.4.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2020 3.5 Autologous Cell Therapy Key Players Head office and Area Served 3.6 Key Players Autologous Cell Therapy Product Solution and Service 3.7 Date of Enter into Autologous Cell Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Autologous Cell Therapy Breakdown Data by Type 4.1 Global Autologous Cell Therapy Historic Market Size by Type (2016-2021) 4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2022-2027) 5 Autologous Cell Therapy Breakdown Data by Application 5.1 Global Autologous Cell Therapy Historic Market Size by Application (2016-2021) 5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Autologous Cell Therapy Market Size (2016-2027) 6.2 North America Autologous Cell Therapy Market Size by Type 6.2.1 North America Autologous Cell Therapy Market Size by Type (2016-2021) 6.2.2 North America Autologous Cell Therapy Market Size by Type (2022-2027) 6.2.3 North America Autologous Cell Therapy Market Size by Type (2016-2027) 6.3 North America Autologous Cell Therapy Market Size by Application 6.3.1 North America Autologous Cell Therapy Market Size by Application (2016-2021) 6.3.2 North America Autologous Cell Therapy Market Size by Application (2022-2027) 6.3.3 North America Autologous Cell Therapy Market Size by Application (2016-2027) 6.4 North America Autologous Cell Therapy Market Size by Country 6.4.1 North America Autologous Cell Therapy Market Size by Country (2016-2021) 6.4.2 North America Autologous Cell Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Autologous Cell Therapy Market Size (2016-2027) 7.2 Europe Autologous Cell Therapy Market Size by Type 7.2.1 Europe Autologous Cell Therapy Market Size by Type (2016-2021) 7.2.2 Europe Autologous Cell Therapy Market Size by Type (2022-2027) 7.2.3 Europe Autologous Cell Therapy Market Size by Type (2016-2027) 7.3 Europe Autologous Cell Therapy Market Size by Application 7.3.1 Europe Autologous Cell Therapy Market Size by Application (2016-2021) 7.3.2 Europe Autologous Cell Therapy Market Size by Application (2022-2027) 7.3.3 Europe Autologous Cell Therapy Market Size by Application (2016-2027) 7.4 Europe Autologous Cell Therapy Market Size by Country 7.4.1 Europe Autologous Cell Therapy Market Size by Country (2016-2021) 7.4.2 Europe Autologous Cell Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Autologous Cell Therapy Market Size (2016-2027) 8.2 Asia-Pacific Autologous Cell Therapy Market Size by Type 8.2.1 Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Autologous Cell Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Autologous Cell Therapy Market Size by Application 8.3.1 Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Autologous Cell Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Autologous Cell Therapy Market Size by Region 8.4.1 Asia-Pacific Autologous Cell Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Autologous Cell Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Autologous Cell Therapy Market Size (2016-2027) 9.2 Latin America Autologous Cell Therapy Market Size by Type 9.2.1 Latin America Autologous Cell Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Autologous Cell Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Autologous Cell Therapy Market Size by Type (2016-2027) 9.3 Latin America Autologous Cell Therapy Market Size by Application 9.3.1 Latin America Autologous Cell Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Autologous Cell Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Autologous Cell Therapy Market Size by Application (2016-2027) 9.4 Latin America Autologous Cell Therapy Market Size by Country 9.4.1 Latin America Autologous Cell Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Autologous Cell Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Autologous Cell Therapy Market Size (2016-2027) 10.2 Middle East & Africa Autologous Cell Therapy Market Size by Type 10.2.1 Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Autologous Cell Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Autologous Cell Therapy Market Size by Application 10.3.1 Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Autologous Cell Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Autologous Cell Therapy Market Size by Country 10.4.1 Middle East & Africa Autologous Cell Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Autologous Cell Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BioTime 11.1.1 BioTime Company Details 11.1.2 BioTime Business Overview 11.1.3 BioTime Autologous Cell Therapy Introduction 11.1.4 BioTime Revenue in Autologous Cell Therapy Business (2016-2021) 11.1.5 BioTime Recent Development 11.2 Pharmicell 11.2.1 Pharmicell Company Details 11.2.2 Pharmicell Business Overview 11.2.3 Pharmicell Autologous Cell Therapy Introduction 11.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2016-2021) 11.2.5 Pharmicell Recent Development 11.3 BrainStorm Cell Therapeutics 11.3.1 BrainStorm Cell Therapeutics Company Details 11.3.2 BrainStorm Cell Therapeutics Business Overview 11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction 11.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) 11.3.5 BrainStorm Cell Therapeutics Recent Development 11.4 Opexa Therapeutics 11.4.1 Opexa Therapeutics Company Details 11.4.2 Opexa Therapeutics Business Overview 11.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction 11.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) 11.4.5 Opexa Therapeutics Recent Development 11.5 Vericel Corporation 11.5.1 Vericel Corporation Company Details 11.5.2 Vericel Corporation Business Overview 11.5.3 Vericel Corporation Autologous Cell Therapy Introduction 11.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2016-2021) 11.5.5 Vericel Corporation Recent Development 11.6 Regeneus 11.6.1 Regeneus Company Details 11.6.2 Regeneus Business Overview 11.6.3 Regeneus Autologous Cell Therapy Introduction 11.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2016-2021) 11.6.5 Regeneus Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Bone Marrow Table 3. Key Players of Epidermis Table 4. Global Autologous Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Autologous Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Autologous Cell Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Autologous Cell Therapy Market Share by Regions (2016-2021) Table 8. Global Autologous Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Autologous Cell Therapy Market Share by Regions (2022-2027) Table 10. Autologous Cell Therapy Market Trends Table 11. Autologous Cell Therapy Market Drivers Table 12. Autologous Cell Therapy Market Challenges Table 13. Autologous Cell Therapy Market Restraints Table 14. Global Autologous Cell Therapy Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Autologous Cell Therapy Market Share by Players (2016-2021) Table 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2020) Table 17. Ranking of Global Top Autologous Cell Therapy Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Autologous Cell Therapy Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Autologous Cell Therapy Product Solution and Service Table 21. Date of Enter into Autologous Cell Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 24. Global Autologous Cell Therapy Revenue Market Share by Type (2016-2021) Table 25. Global Autologous Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Autologous Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Autologous Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Autologous Cell Therapy Revenue Market Share by Application (2016-2021) Table 29. Global Autologous Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Autologous Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 32. North America Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 34. North America Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Autologous Cell Therapy Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Autologous Cell Therapy Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 61. BioTime Company Details Table 62. BioTime Business Overview Table 63. BioTime Autologous Cell Therapy Product Table 64. BioTime Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 65. BioTime Recent Development Table 66. Pharmicell Company Details Table 67. Pharmicell Business Overview Table 68. Pharmicell Autologous Cell Therapy Product Table 69. Pharmicell Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 70. Pharmicell Recent Development Table 71. BrainStorm Cell Therapeutics Company Details Table 72. BrainStorm Cell Therapeutics Business Overview Table 73. BrainStorm Cell Therapeutics Autologous Cell Therapy Product Table 74. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 75. BrainStorm Cell Therapeutics Recent Development Table 76. Opexa Therapeutics Company Details Table 77. Opexa Therapeutics Business Overview Table 78. Opexa Therapeutics Autologous Cell Therapy Product Table 79. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 80. Opexa Therapeutics Recent Development Table 81. Vericel Corporation Company Details Table 82. Vericel Corporation Business Overview Table 83. Vericel Corporation Autologous Cell Therapy Product Table 84. Vericel Corporation Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 85. Vericel Corporation Recent Development Table 86. Regeneus Company Details Table 87. Regeneus Business Overview Table 88. Regeneus Autologous Cell Therapy Product Table 89. Regeneus Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million) Table 90. Regeneus Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Autologous Cell Therapy Market Share by Type: 2020 VS 2027 Figure 2. Bone Marrow Features Figure 3. Epidermis Features Figure 4. Global Autologous Cell Therapy Market Share by Application: 2020 VS 2027 Figure 5. Neurology Case Studies Figure 6. Orthopedics Case Studies Figure 7. Cancer Case Studies Figure 8. Wound Healing Case Studies Figure 9. Other Case Studies Figure 10. Autologous Cell Therapy Report Years Considered Figure 11. Global Autologous Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Autologous Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Autologous Cell Therapy Market Share by Regions: 2020 VS 2027 Figure 14. Global Autologous Cell Therapy Market Share by Regions (2022-2027) Figure 15. Global Autologous Cell Therapy Market Share by Players in 2020 Figure 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2020 Figure 18. Global Autologous Cell Therapy Revenue Market Share by Type (2016-2021) Figure 19. Global Autologous Cell Therapy Revenue Market Share by Type (2022-2027) Figure 20. North America Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Autologous Cell Therapy Market Share by Type (2016-2027) Figure 22. North America Autologous Cell Therapy Market Share by Application (2016-2027) Figure 23. North America Autologous Cell Therapy Market Share by Country (2016-2027) Figure 24. United States Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Autologous Cell Therapy Market Share by Type (2016-2027) Figure 28. Europe Autologous Cell Therapy Market Share by Application (2016-2027) Figure 29. Europe Autologous Cell Therapy Market Share by Country (2016-2027) Figure 30. Germany Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Autologous Cell Therapy Market Share by Type (2016-2027) Figure 38. Asia-Pacific Autologous Cell Therapy Market Share by Application (2016-2027) Figure 39. Asia-Pacific Autologous Cell Therapy Market Share by Region (2016-2027) Figure 40. China Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Autologous Cell Therapy Market Share by Type (2016-2027) Figure 48. Latin America Autologous Cell Therapy Market Share by Application (2016-2027) Figure 49. Latin America Autologous Cell Therapy Market Share by Country (2016-2027) Figure 50. Mexico Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Autologous Cell Therapy Market Share by Type (2016-2027) Figure 54. Middle East & Africa Autologous Cell Therapy Market Share by Application (2016-2027) Figure 55. Middle East & Africa Autologous Cell Therapy Market Share by Country (2016-2027) Figure 56. Turkey Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 60. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 61. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 62. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 63. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 64. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

BioTime Pharmicell BrainStorm Cell Therapeutics Opexa Therapeutics Vericel Corporation Regeneus